Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy
Titel:
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy
Auteur:
Al Zaki, Ajlan Feng, Lei Watson, Grace Ahmed, Sairah A. Mistry, Haleigh Nastoupil, Loretta J. Hawkins, Misha Nair, Ranjit Iyer, Swaminathan P. Lee, Hun J. Steiner, Raphael E. Flowers, Christopher R. Shpall, Elizabeth J. Kebriaei, Partow Neelapu, Sattva S. Westin, Jason R. Strati, Paolo